Benzinga - Mon, 19 Apr 2021 05:19:22 -0400
Benzinga - Thu, 15 Apr 2021 16:06:40 -0400
load more
Sector: Health Care.Industry: Biotechnology
Veracyte Inc is a genomic diagnostics company. It provides genomic diagnostic products and services to improve patient care against diseases such as thyroid cancer, lung cancer, and idiopathic pulmonary fibrosis. The firm's product portfolio consists of products such as Afirma analysis, Percepta, Envisia, and others. The company derives its revenues from the Sale of Afirma analysis product.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-10
REV
Q4 2020Est.ActualSurprise
EPS-0.110-0.140 -0.0300
REV31.930M34.536M2.606M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
VCYTVeracyte1.23%3B

Veracyte Company Questions & Answers

Q

How do I buy Veracyte (VCYT) stock?

A

You can purchase shares of Veracyte (NASDAQ: VCYT) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Veracyte's (VCYT) main competitors?

Q

What is the target price for Veracyte?

A

The latest price target for Veracyte (NASDAQ: VCYT) was reported by Morgan Stanley on 2021-02-22. The analyst firm set a price target for 65.00 expecting VCYT to rise to within 12 months (a possible 46.56% upside). 12 analyst firms have reported ratings in the last year.

Q

How much is Veracyte (VCYT) stock ?

A

The stock price for Veracyte (NASDAQ: VCYT) is $44.35 last updated Fri May 07 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

When is the next Veracyte (VCYT) dividend?

A

There are no upcoming dividends for Veracyte.

Q

When is Veracyte (NASDAQ:VCYT) reporting earnings?

A
Veracyte’s Q2 earnings are confirmed after-market from now on July 29, 2021.
Q

When is the upcoming split for VCYT?

A

There is no upcoming split for Veracyte.